1,902,201 Outset Medical (OM) shares held via BML fund
Rhea-AI Filing Summary
Outset Medical, Inc. reports a major shareholder’s existing stake. A 10% owner associated with BML Investment Partners, L.P. reports indirect beneficial ownership of 1,902,201 shares of Outset Medical common stock as of 02/12/2026. These shares are held by BML Investment Partners, L.P., whose general partner is BML Capital Management, LLC, managed by Mr. Leonard. He exercises investment and voting control over the fund’s shares but disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- [object Object]
FAQ
Who is the reporting person in the Outset Medical (OM) Form 3 filing?
The reporting person is Leonard Braden Michael, associated with BML Capital Management, LLC. He is identified as a 10% owner of Outset Medical through indirect holdings in BML Investment Partners, L.P., over which he exercises investment and voting control.
Does the Outset Medical (OM) Form 3 show any new stock transactions?
The Form 3 reflects beneficial ownership of existing holdings rather than new transactions. It lists 1,902,201 common shares held indirectly through BML Investment Partners, L.P., serving as an initial statement of ownership for a 10% owner.
What ownership disclaimer does Mr. Leonard make in the Outset Medical (OM) Form 3?
Mr. Leonard disclaims beneficial ownership of shares held by BML Investment Partners, L.P., except to the extent of his pecuniary interest. Although he controls investment and voting decisions, he clarifies limits on his beneficial ownership of the fund’s Outset Medical shares.